2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
51
Small Cell Lung Carcinoma
23
Breast Neoplasms
18
Sarcoma
16
Lung Neoplasms
10
Carcinoma, Hepatocellular
10
Esophageal Squamous Cell Carcinoma
9
Stomach Neoplasms
8
Neoplasms
8
Triple Negative Breast Neoplasms
7
Ovarian Neoplasms
7
Nasopharyngeal Carcinoma
7
Thyroid Neoplasms
6
Neoplasm Metastasis
6
Esophageal Neoplasms
6
Pancreatic Neoplasms
5
NSCLC
5
Colorectal Neoplasms
5
Carcinoma
5
Uterine Cervical Neoplasms
4
Pheochromocytoma
4
Endometrial Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Ovarian Epithelial
4
Recurrence
3
Paraganglioma
3
Non-squamous Non-small Cell Lung Cancer
3
Glioma
3
Fallopian Tube Neoplasms
3
Cholangiocarcinoma
3
Interventions
trifluridine tipiracil drug combination
1
camrelizumab
1
anlotinib
1
Radiotherapy
1
Induction Chemotherapy
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
ESCC
×
anlotinib
×
Clear all
NCT04471480
2020-07-15
TC
Third Military Medical University
Phase NA
Unknown
90 enrolled